146
Views
29
CrossRef citations to date
0
Altmetric
Original

ROS and protein oxidation in early stages of cytotoxic drug induced apoptosis

, &
Pages 1124-1137 | Received 24 Mar 2006, Published online: 07 Jul 2009
 

Abstract

Cytotoxic drugs induce cell death through induction of apoptosis. This can be due to activation of a number of cell death pathways. While the downstream events in drug induced cell death are well understood, the early events are less clear. We therefore used a proteomic approach to investigate the early events in apoptosis induced by a variety of drugs in HL60 cells. Using 2D-gel electrophoresis, we were able to identify a number of protein changes that were conserved between different drug treatments. Identification of post-translational modifications (PTM) responsible for these proteome changes revealed an increase in protein oxidation in drug treated cells, as well as changes in protein phosphorylation. We demonstrate an accumulation of oxidised proteins within the ER, which lead to ER stress and calcium release and may result in the induction of apoptosis. This study demonstrates the importance of ROS mediated protein modifications in the induction of the early stages of apoptosis in response to chemotherapeutic drug treatment.

Abbreviations
ER=

endoplasmic reticulum

H2DCFDA=

2′7′-dichlorodihydrofluorescein diacetate (2′7′-dichlorofluorescin diacetate)

NAC=

N-acetyl-l-cysteine

PDI=

protein disulphide isomerase

PTM=

post-translational modification

ROS=

reactive oxygen species

TBS=

Tris-buffered saline

UPR=

unfolded protein response

zVAD-fmk=

Z-Val-Ala-Asp.fluoromethyketone

Abbreviations
ER=

endoplasmic reticulum

H2DCFDA=

2′7′-dichlorodihydrofluorescein diacetate (2′7′-dichlorofluorescin diacetate)

NAC=

N-acetyl-l-cysteine

PDI=

protein disulphide isomerase

PTM=

post-translational modification

ROS=

reactive oxygen species

TBS=

Tris-buffered saline

UPR=

unfolded protein response

zVAD-fmk=

Z-Val-Ala-Asp.fluoromethyketone

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.